Rating Change
Barclays reiterated its Equal-Weight rating on Amgen Inc. (NASDAQ:AMGN) on August 14, 2026.
reiterateNASDAQ:AMGN
Barclays Reiterates Equal-Weight Rating on Amgen Inc. (AMGN)
Barclays reiterated its Equal-Weight rating on Amgen Inc. (NASDAQ:AMGN) on August 14, 2026.
At publication ·
What changed
Amgen Inc. (NASDAQ:AMGN) · reiterate
- Firm
- Barclays
- Rating
- Equal-Weight to Equal-Weight
- Price at event
- $412.35
- Market capitalization
- $209.2B
At a glance
Key takeaways
- Barclays reiterated an Equal-Weight rating on Amgen on August 14, 2026, indicating the analyst sees limited upside or downside from current levels.
Market Context
Amgen Inc. operates in the Healthcare sector. The stock currently trades at $412.35 with a market capitalization of $209.2B. The stock has gained 22.5% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Amgen Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Amgen Inc.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | Barclays | Equal-Weight | N/A |
| Aug 10, 2026 | Guggenheim | Neutral | N/A |
| Aug 07, 2026 | Citigroup | Neutral | N/A |
| Aug 06, 2026 | Bernstein | Market Perform | N/A |
| Aug 05, 2026 | Wells Fargo | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View AMGN Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for AMGN?
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Amgen Inc. (NASDAQ:AMGN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AMGN forecast page.